News Coverage 07.09.20 Share on Twitter Share on Facebook Share on LinkedIn How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease Related Announcement PICI 2024: Collaborative Breakthroughs in Cancer Immunotherapy Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research Announcement PICI Network Investigators Propel Immunotherapy Progress at SITC 2024
Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research